Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

Pharmaceuticals

De-Risking Supply Chains: Big Pharma Turns To India To Reduce Reliance On China

3d News Headlines

Representative Image

Kerala Ayurveda Wins Rare US Patent For Herbal Formulation Uniquely Processed In Ancient Indian Tradition

Anand Parthasarathy

Health from herbs... it all starts here (representational image)

Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know

Bhaswati Guha Majumder

Johnson & Johnson

All You Need To Know About Merck’s Covid Pill That Cuts Risk Of Death And Hospitalisation By 50 Per Cent

Bhaswati Guha Majumder

Merck’s Covid anti-viral pill (Representative Image)

Pakistan Lifts Ban On Import Of Lifesaving Drugs From India Over Fears Of Potentially Severe Shortages

Pak PM Imran Khan (Pic Via Twitter)

IIT Guwahati Collaborates With Hester Biosciences To Develop Vaccine Against Coronavirus

IIT Guwahati campus (Wikimedia Commons)

Indian Pharma Exports Surge 11 Percent in First Quarter; See 21 Percent Jump In July

Medical drugs and a thermometer. (Pixabay/Steve Buissinne)

Modi Government 2.0 Looks To Introduce E-Pharmacy Project Within First 100 Days Of Power

Representative Image. (Creative commons by stevepb on pixabay)

Government Ban Works: Unsafe FDC Medicine Sales Down By 56.4 Per Cent, Non-FDCs Up By 9.2 Per Cent

Representative image. (Unsplash/Simone van der Koelen)

Headache Gone For Piramal Enterprise: SC Exempts Saridon From Banned List In India

Representative image (Facebook)

Can’t Judge A Medicine By Its Name: Government To Regulate Brands Under Which Medicines Are Sold

Representative image. (Prasad Gori/Hindustan Times via Getty Images)

Gujarat Emerges As The Number One State In Manufacturing Quality Medicines In India

Medicinal pills. (Scott Olson/Getty Images)

Blocked At Doklam, What Will China Do Next? India Needs To Be Ready On Many Fronts

Troubled border

Rs 5.3 Lakh Crore Flowed Out Of India Illegally in 2007: Government Report

India currency notes (INDRANIL MUKHERJEE/AFP/Getty Images))

Delhi HC Quashes Centre’s Ban On 344 FDC Medicines After Pharma Company Petitions

An Indian pharmacy shop assistant counts a strip of tablets. Photo credit: DESHAKALYAN CHOWDHURY/AFP/Getty Images

Indian Pharma Sector Gets A Thumbs-Up From Moody’s

Indian pharmaceutical research (INDRANIL MUKHERJEE/AFP/Getty Images)

Why Indian Pharma Sector Should Move From Generic To Innovation

Nilanjan Banik and Philip Stevens

Indian pharmaceutical research (INDRANIL MUKHERJEE/AFP/Getty Images)

Get Swarajya in your inbox.